Link found between Actos and Bladder Cancer.
The diabetes medication Actos (pioglitazone) may be associated with an increased risk of bladder cancer.
The U.S. Food and Drug Administration (FDA) issued a safety announcement June 15, 2011 – click to learn more from the FDA.
“FDA is also aware of a recent epidemiological study conducted in France which suggests an increased risk of bladder cancer with pioglitazone. Based on the results of this study, France has suspended the use of pioglitazone and Germany has recommended not to start pioglitazone in new patients.” Source – FDA (http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm)
may be linked to serious side effects that include:
- Bladder Cancer
- Kidney Cancer
- Heart Attacks
- Bladder Infections
Contact Goldberg Attorneys
If you have been diagnosed with bladder cancer after having taken ACTOS, then you might be eligible for financial compensation. For more information, please contact us.